Search:

Pharmaceuticals Headlines from PR Newswire


< Go Back

Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter
Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer
Edison Pharmaceuticals Announces Phase 2 Positive Clinical Results for EPI-743 in Rett Syndrome
Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration
ATL1103 Phase II Trial - Successful Efficacy Results
Leading Intellectual Property Counsel, James Kellerman, Joins Astellas as Vice President
Dr. Jeanne M. Novak, President & CEO Of CBR International Corp.®, To Attend World Health Organization (WHO) Meeting To Address Leading Experimental Treatments And Vaccines For The Ebola Virus, September 4 - 5, 2014, Geneva, Switzerland
Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043
Lawsuit Challenges Iowa Health Mandate that Forces Employers to Pay More for Prescription Drugs
Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021
XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer
Ameritox Research Report Reveals Pain Patients' Role in Current Heroin Epidemic
XTL Biopharmaceuticals Provides Financial and Operational Update for the Second Quarter of 2014
Chiral Chromatography Column Market Worth $87.8 Million by 2018
Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke
Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources
Quinolone Vigilance Foundation Warns Levaquin, Cipro, Avelox May Result In Neurodegenerative Diseases
Meijer Pharmacy Busts Myths on Flu Shots
BioLegend Acquires the Antibody Products Business Unit from Covance
Australia Medical Devices Market worth $10.4 billion by 2020 Says a New Report Available at MarketOptimizer.org
Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline
ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure
PANTHERx Specialty Pharmacy Applying for URAC Specialty Pharmacy Accreditation
EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology
Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK
Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients
MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome
ESC Hot Line: Data Reports NVAF Patients Taking Pradaxa® (dabigatran etexilate mesylate) Experienced Slower Decline in Kidney Function Compared to Those on Warfarin
Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency English
VentiRx Pharmaceuticals Announces Fast Track Designation Granted for Motolimod (VTX-2337), a Novel Immunotherapy for Women with Ovarian Cancer
Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension
BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences
VentiRx Pharmaceuticals Provides Corporate and Clinical Update English
Celsion Announces Enrollment of First Patient in Global Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer
Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th
Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel
Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent
Dipexium Pharmaceuticals Announces Presentation at Rodman & Renshaw 16th Annual Global Investment Conference
Update on the Phase III multicenter, double-blind STEP study of Ampion™ for Osteoarthritis of the Knee
Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company
Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine
Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection English
Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014
CDC vaccine scientist admits wrongdoing.
Sinovac to Participate in Upcoming Investor Conferences
CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz
Contract Research Organization WCCT Global Celebrates Being Named as One of the Fastest Growing Companies in America
Pulse Oximeter Industry and Moisture Analyzer Market Forecasts of Global and China Regions for 2014-2020
Prosonix' Marketing Authorisation Application for PSX1001 - a Generic Version of GlaxoSmithKline's Flixotide® Evohaler® - Under Assessment in EU
Drug Discovery Technologies - A Global Market Overview

< Prev Next >
PR Newswire - United Business Media